Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00923481What this trial is testingA Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...Who this might be right forHead and Neck NeoplasmsPheochromocytomaColorectal Neoplasms+2 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05672316What this trial is testingBotensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior ChemotherapyWho this might be right forAdvanced Colorectal AdenocarcinomaAdvanced Microsatellite Stable Colorectal CarcinomaMetastatic Colorectal Adenocarcinoma+3 more City of Hope Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013What this trial is testingA Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursWho this might be right forBladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more Cancer Research UK 81
Testing effectiveness (Phase 2)Study completedNCT00033384What this trial is testingCI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00022477What this trial is testingBMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal CancerWho this might be right forColorectal Cancer University of Chicago 24
Testing effectiveness (Phase 2)WithdrawnNCT00070434What this trial is testingS0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the RectumWho this might be right forColorectal Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT03126110What this trial is testingPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 145
Not applicableNot Yet RecruitingNCT07410767What this trial is testingAdvanced Endoscopic Resections for Rectal NeoplasmsWho this might be right forRectal CancerRectal AdenocarcinomaRectal Adenoma+2 more Jagiellonian University 300
Early research (Phase 1)Active Not RecruitingNCT06607185What this trial is testingThe Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT06333314What this trial is testingDostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIWho this might be right forPancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more UNICANCER 120
Testing effectiveness (Phase 2)Study completedNCT00006094What this trial is testingOxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumWho this might be right forAdenocarcinoma of the RectumStage II Rectal CancerStage III Rectal Cancer National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00766155What this trial is testingChemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal CancerWho this might be right forColorectal Cancer European Organisation for Research and Treatment of Cancer - EORTC 1,094
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938What this trial is testingPhase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)Who this might be right forLocally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more Tao Zhang 70
Early research (Phase 1)Active Not RecruitingNCT03872947What this trial is testingTRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsWho this might be right forSolid TumorColorectal CancerCholangiocarcinoma+9 more Toray Industries, Inc 138
Testing effectiveness (Phase 2)Study completedNCT00005818What this trial is testingSU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Study completedNCT00003950What this trial is testingIrinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal CancerWho this might be right forColorectal Cancer University of Chicago 16
Testing effectiveness (Phase 2)UnknownNCT03047525What this trial is testingStudy of DC-CTL Combined With CIK for Advanced Solid TumorWho this might be right forColorectal CancerRenal Cell CarcinomaNasopharyngeal Carcinoma+1 more Xiaoyi Huang 200
Early research (Phase 1)UnknownNCT04660929What this trial is testingCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsWho this might be right forHER2-positiveAdenocarcinomaBile Duct Cancer+28 more Carisma Therapeutics Inc 48